RxDoctor Payments Data

Cameron Wheeler, PA

Physician Assistant · Reno, NVNPI 1831859974

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,938 of the $11,062 with a category attached, or 71.8%. 23 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 33.2% of the total. 2025 is the largest year on record at $5,423, more than ten times the $270 reported in 2023. Among physician assistant clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,062in general payments, 2019–2025

Across 255 payments — averaging $43.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Saluda Medical Americas, Inc.$4K
  • Boston Scientific$3K
  • Nevro Corp.$685
  • Medtronic$539
  • Si-bone, Inc.$502
  • Abbott$393
  • plus $2K from 17 others

What the payments were for

  • Travel & lodging$3,12428%
  • Food & beverage$7,93872%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,062 in reported general payments places this provider in the 95th percentile of 881 physician assistant providers in Nevada.

See all physician assistant providers in Nevada

Medicare billing

Part B allowed, 2024
$56,238
Medicare patients
132
Services billed
837

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen303$8,731
BelbucaBuprenorphine Hcl11$8,610
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen164$6,290
Buprenorphine26$5,550
MovantikNaloxegol Oxalate12$4,910
Pregabalin161$4,596
Oxycodone Hcl238$4,572
Morphine Sulfate ErMorphine Sulfate130$3,784
OxycontinOxycodone Hcl14$3,708
Tizanidine Hcl112$3,382
Lidocaine27$2,836
Gabapentin138$1,716
Celecoxib84$1,685
Naloxone Hcl17$1,183
Cyclobenzaprine Hcl80$934

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$44$8,61011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 881 physician assistant providers in Nevada.

Other physician assistant in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →